Emergent BioSolutions
EBS
#8824
Rank
HK$1.79 B
Marketcap
HK$35.07
Share price
-7.64%
Change (1 day)
-45.25%
Change (1 year)

EPS for Emergent BioSolutions (EBS)

EPS in 2026 (TTM): -HK$1.33

According to Emergent BioSolutions 's latest financial reports the company's current EPS (TTM) is -HK$1.33. In 2025 the company made an earnings per share (EPS) of HK$7.45 an increase over its 2024 EPS that were of -HK$28.48.

EPS history for Emergent BioSolutions from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$1.33-117.83%
2025HK$7.45-126.17%
2024-HK$28.48-75.61%
2023-HK$116.77232.21%
2022-HK$35.15-203.46%
2021HK$33.97-25.09%
2020HK$45.35445.28%
2019HK$8.32-15.2%
2018HK$9.81-35.9%
2017HK$15.3069.57%
2016HK$9.02-27.67%
2015HK$12.4765.63%
2014HK$7.5311.63%
2013HK$6.7532.31%
2012HK$5.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$10.28-870.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.05-2,202.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.49-2,386.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-HK$20.79 1,458.82%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$2.75-305.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$33.42 2,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$10.75-905.88%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel